Meehan K, Redfern A, Khan A, Pachter N, Spalding L, Redfern C, Maynard M, Pilkington L. Lower rates of mutations in breast cancer risk genes among Aboriginal and Torres Strait Island women. Medical Journal of Australia 2025 (under review).
Enzalutamide Versus Enzalutamide Plus 177Lu-PSMA-617 In Poor-Risk, Metastatic, Castrate-Resistant Prostate Cancer: A Randomised Phase 2 Trial (ANZUP 1901). ENZA-P. Emmett et al. Lancet Oncology. Lancet Oncol 2024; 25: 563–71.
Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer. Hoon et al. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD011220.
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer. Golden et al. Nature Communications. 2021 Mar 26;12(1):1920.
177Lu-PSMA-617 versus Cabazitaxel in Metastatic Castration Resistant Prostate Cancer. Hofman et al. Lancet. 2021 Feb 27;397(10276):797-804.
Darcey E, Lloyd R, Cadby G, Pilkington L, Redfern A, Thompson SC, Saunders C, Wylie E, Stone J. The association between mammographic density and breast cancer risk in Western Australian Aboriginal women. Breast Cancer Res Treat. 2019 Jul;176(1):235-242.
Controversies Around Epithelial Mesenchymal Plasticity In Cancer Metastasis. Williams et al. Nature Reviews Cancer. 2019 Oct; 19: 716–732.
McLean, K., Darcey, E., Cadby, G. Lund H, Pilkington L, Redfern A, Thompson SC, Saunders C, Wylie E, Stone J. The distribution and determinants of mammographic density measures in Western Australian aboriginal women. Breast Cancer Res 21, 33 (2019).
Pilkington L, Haigh M, Durey A, Katzenallenbogen J, Thompson SC (2017) Perspectives of Aboriginal women on participation in mammographic screening: a step towards improving services. BMC Public Health. 17:697.
Hormone receptor positive, HER2 negative metastatic breast cancer: future treatment landscape. Redfern et al. Asia Pac J Clin Oncol. 2016 Mar;12 Suppl 1:19-31.
Thompson SC, Shahid S, DiGiacomo M, Pilkington L and Davidson PM (2014) Making progress: the role of Cancer Councils in Australia in Indigenous cancer control. BMC Public Health. 14:347.
